Experimental rectal cancer drug caused all patients' tumors to disappear in small trial

6/6/2022 11:49:00 PM

So far, no patient has needed further treatment.

Channel_Other, Type_News

Experimental rectal cancer drug caused all patients' tumors to disappear in small trial

So far, no patient has needed further treatment.

In an unprecedented clinical trial, a dozen rectal cancer patients saw their tumors disappear after they received an experimental drug called dostarlimab, and none of the patients experienced significant side effects from the treatment.You may click on “ Your Choices ” below to learn about and use cookie management tools to limit use of cookies when you visit NPR’s sites.The New York Times .endoscopic tests, and physical exams.

  "I believe this is the first time this has happened in the history of cancer ," in that this is the first cancer trial in which every patient entered remission, Dr. Luis Alberto Diaz, Jr. If you click “ Agree and Continue ” below, you acknowledge that your cookie choices in those tools will be respected and that you otherwise agree to the use of cookies on NPR’s sites., one of the trial leaders and a medical oncologist at Memorial Sloan… .   However, MMRd mutations can also make cancer cells more vulnerable to immune response, especially it's bolstered by an immunotherapy agent – in this case, a checkpoint inhibitor , which unleashes restrictions on immune cells so they can more effectively kill cancer cells.

Read more:
Live Science »

Rivals.com - Nick at Nite: Mid-South developments ahead of Early Signing Period

Read more >>

Incredible and awesome. I hope they find this useful against other cancers

NPR Cookie Consent and Choices

Every Single Patient in This Small Experimental Drug Trial Saw Their Cancer DisappearIn what appears to be a very promising breakthrough for the treatment of rectal cancer, a small drug trial conducted in the US found every patient treated in the experiment had their cancer successfully go into remission. How can I get this treatment?

Small Rectal Cancer Study Has Remission in Every PatientA small clinical trial with 12 rectal cancer patients found remission in 100% of them, according to a new paper published in The New England Journal of Medicine . 12? that is worthless absent to the 12 participants Another 'cancer cure' study for which we will surely have to wait '10 years' to prove it well. It's the story I've heard for years, they find something that heals and you have to wait 10 years, which later are forever because the treatments never appear. Saw the endoscopies here on tt of the patients ,please do share again if you have

Small Cancer Trial Delivers ‘Unheard-of' Result: Complete Remission for EveryoneA small NYC-led cancer trial has achieved a result reportedly never before seen – the total remission of cancer in all of its patients. To be sure, the trial — led by doctors at Memorial Sloan Kettering and backed by drug maker GlaxoSmithKline — has only completed treatment of 12 patients, with a specific cancer in its early stages and… It’s been out there for years they just have a pile of other medicines they had to sell first. Elementary my dear Mr. Watson, elementary!

Breast cancer drug shows promise, opens new treatment possibilities to thousands of patientsFor the first time, a drug targeting a protein that drives breast cancer growth has been shown to work against tumors with very low levels of the protein.

Breast cancer drug shows promise, opens new treatment possibilities to thousands of patientsFor the first time, a drug targeting a protein that drives breast cancer growth has been shown to work against tumors with very low levels of the protein.

In an unprecedented clinical trial, a dozen rectal cancer patients saw their tumors disappear after they received an experimental drug called dostarlimab, and none of the patients experienced significant side effects from the treatment.You may click on “ Your Choices ” below to learn about and use cookie management tools to limit use of cookies when you visit NPR’s sites.The New York Times .endoscopic tests, and physical exams.

  "I believe this is the first time this has happened in the history of cancer ," in that this is the first cancer trial in which every patient entered remission, Dr. Luis Alberto Diaz, Jr. If you click “ Agree and Continue ” below, you acknowledge that your cookie choices in those tools will be respected and that you otherwise agree to the use of cookies on NPR’s sites., one of the trial leaders and a medical oncologist at Memorial Sloan… .   However, MMRd mutations can also make cancer cells more vulnerable to immune response, especially it's bolstered by an immunotherapy agent – in this case, a checkpoint inhibitor , which unleashes restrictions on immune cells so they can more effectively kill cancer cells.